Abstract:AIM:To examine the effect of celecoxib on tumor growth and angiogenesis in an orthotopic implantation tumor model of colon cancer.METHODS:Human colorectal adenocarcinoma HT-29 cells were implanted subcutaneously in nude mice. Four groups of animals received different doses of celecoxib after tumor implantation. After 42 days, all animals were evaluated for changes in body weight, the volume and weight of colorectal tumors, and tumor growth inhibition. The content of prostaglandin E(2) (PGE(2)) in the tumor tissue homogenate was estimated by radioimmunoassay (RIA). Cyclooxygenase-2 (COX-2) and CD34 expression in tumor tissue was assessed by immunohistochemistry, and the microvessel density (MVD) of tumor tissue was determined. Apoptosis of the tumor cells was detected by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). The expression of vascular endothelial growth factor (VEGF) mRNA and matrix metalloproteinase-2 (MMP-2) mRNA extracted from the tumor tissue was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR).RESULTS:There was no statistically significant change in the animals' body weight between the treatment groups. However, with increasing doses of celecoxib, the volume and weight of the tumor decreased. The rates of tumor growth inhibition for the L (low), M (medium) and H (high) groups were 25.30%, 38.80%, and 76.92%, respectively, which were significant compared to the C (control) group. There were significant differences in COX-2 expression in the tumor tissue between all groups, except between the L and M groups. Celecoxib exposure also reduced PGE2 levels in the tumor tissue homogenates. The level of PGE(2) correlated to the weight of tumor (r=0.8814, P < 0.05) and to COX-2 expression (r=0.8249, Puse < 0.05). Compared to the control group, the tumor cells from celecoxib-treated mice had a significantly higher apoptotic index. Celecoxib also decreased CD34(+) expression in tumors from treated mice. There were significant differences in the MVD between all groups except between groups H and M. Celecoxib significantly reduced the expression of VEGF and MMP-2 mRNA in the group H but not in L and M groups. The MVD in tumor tissue was closely related to the PGE2 levels, as well as the expression of VEGF and MMP-2 mRNA (r = 0.9006, r = 0.8573 and r = 0.6427, respectively; P < 0.05).CONCLUSIONS:By inhibiting COX-2, PGE(2) synthesis, and VEGF and MMP-2 mRNA expression in tumor tissue, celecoxib enhances tumor cell apoptosis, thereby inhibiting the growth and angiogenesis of orthotopically implanted tumors in a mouse model of human colorectal cancer.

[Celecoxib Inhibits Gastric Adenocarcinoma Growth Via Inducing Expression of Human Nonsteroidal Anti-Inflammatory Drug Activated Gene].

[Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF) in Pancreatic Carcinoma].

[Celecoxib Induces Apoptosis and Inhibits Angiogenesis in Gastric Cancer].

Preoperative Growth Inhibition of Human Gastric Adenocarcinoma Treated with a Combination of Celecoxib and Octreotide

Cyclooxygenase-2 inhibition as a strategy for treating gastric adenocarcinoma.

Celecoxib inhibits the growth of gastric cancer cells not expressing COX-2 in vitro

[Inhibitory Effects of Celecoxib Combined with Octreotide on Growth of Multidrug Resistant Human Gastric Cancer Cell Line SGC7901/ADR].

Effect of Celecoxib on E-cadherin, VEGF, Microvessel Density and Apoptosis in Gastric Cancer

[Effect of a Selective COX-2 Inhibitor on Cell Proliferation and Apoptosis in Human Gastric Cancer Cell Line BGC-823].

Anticancer Effect of Celecoxib via COX-2 Dependent and Independent Mechanisms in Human Gastric Cancers Cells

[Short-Term Preoperative Treatment of Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, on E-cadherin Expression in Gastric Carcinoma Tissues].

Effects of Non‐cytotoxic Drugs on the Growth of Multidrug‐resistance Human Gastric Carcinoma Cell Line

Chemoprevention of Gastric Cancer by Celecoxib in Rats.

Celecoxib Inhibits Tumor Growth and Angiogenesis in an Orthotopic Implantation Tumor Model of Human Colon Cancer.

[The Effects of Selective Cyclooxygenase-2 Inhibitors on the Growth of Gastric Adenocarcinoma].

Experimental Study on Inhibitive Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Lung Adenocarcinoma

[Influence of Selective Cyclooxygenase-2 Inhibitor on Proliferation of Human Gastric Cancer Cells].

[The Inhibitive Effects of Celecoxib Combined with Octreotide on the Metastasis of Human Gastric Cancer in Vivo].

Chemoprevention of Gastric Cancer by Cyclooxygenase-2 Inhibitor in Rats

Modulating Effect of Celecoxib to Proliferation and Molecular Mechanism in MGC803 of Gastric Carcinoma Cell Line

Effects of EGFR Inhibitor AG1478 in Combination with Celecoxib on the Growth of Gastric Cancer Cells